You are here

  • Home
  • Archive
  • Volume 81, Issue 3
  • Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA

Article info

Article menu
Letter
Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA

Authors

  • Klara Martinsson Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden PubMed articlesGoogle scholar articles
  • Kerstin Dürholz Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Mario M Zaiss Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Alf Kastbom Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mario M Zaiss, FAU, Erlangen 91054, Germany; mario.zaiss{at}uk-erlangen.de
View Full Text

Citation

Martinsson K, Dürholz K, Schett G, et al
Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA
Annals of the Rheumatic Diseases 2022;81:445-447.

Publication history

  • Received August 20, 2021
  • Accepted October 27, 2021
  • First published November 24, 2021.
Online issue publication 
February 14, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.